Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Serge Lehmann

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|June 25, 2005
Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspectiveFrank Serge Lehmann, Christoph Beglinger
Expert Opinion on Pharmacotherapy|February 16, 2005
Role of pantoprazole in the treatment of gastro-oesophageal reflux diseaseFrank Serge Lehmann, Christoph Beglinger
Digestion|November 12, 2003
Current role of Helicobacter pylori stool testsFrank Serge Lehmann, Christoph Beglinger
Digestion|October 12, 2012
Monitoring of therapy for inflammatory bowel diseaseEmanuel Burri, Christoph Beglinger, Frank Serge Lehmann
Digestive Diseases and Sciences|June 19, 2015
Reply: To PMID 25344905Emanuel Burri, Christoph Beglinger, Frank Serge Lehmann
Digestive Diseases and Sciences|October 27, 2014
Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitisEmanuel Burri, Christoph Beglinger, Stefanie von Felten, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2012
Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfortEmanuel Burri, Michael Manz, Claude Rothen, et al.
Frontiers in Oncology|October 29, 2021
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous AdenomasLuigi Tornillo, Frank Serge Lehmann, Andrea Garofoli, et al.
BMC Gastroenterology|April 1, 2014
Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriatenessEmanuel Burri, Michael Manz, Patricia Schroeder, et al.
BMC Gastroenterology|January 12, 2012
Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational studyMichael Manz, Emanuel Burri, Claude Rothen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|June 25, 2005
Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspectiveFrank Serge Lehmann, Christoph Beglinger
Expert Opinion on Pharmacotherapy|February 16, 2005
Role of pantoprazole in the treatment of gastro-oesophageal reflux diseaseFrank Serge Lehmann, Christoph Beglinger
Digestion|November 12, 2003
Current role of Helicobacter pylori stool testsFrank Serge Lehmann, Christoph Beglinger
Digestion|October 12, 2012
Monitoring of therapy for inflammatory bowel diseaseEmanuel Burri, Christoph Beglinger, Frank Serge Lehmann
Digestive Diseases and Sciences|June 19, 2015
Reply: To PMID 25344905Emanuel Burri, Christoph Beglinger, Frank Serge Lehmann
Digestive Diseases and Sciences|October 27, 2014
Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitisEmanuel Burri, Christoph Beglinger, Stefanie von Felten, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2012
Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfortEmanuel Burri, Michael Manz, Claude Rothen, et al.
Frontiers in Oncology|October 29, 2021
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous AdenomasLuigi Tornillo, Frank Serge Lehmann, Andrea Garofoli, et al.
BMC Gastroenterology|April 1, 2014
Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriatenessEmanuel Burri, Michael Manz, Patricia Schroeder, et al.
BMC Gastroenterology|January 12, 2012
Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational studyMichael Manz, Emanuel Burri, Claude Rothen, et al.
Pageof 2